Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 3 for D.O.R.C. Dutch Opthalmic Research Center Intl B.V..
D.O.R.C. Dutch Opthalmic Research Center Intl B.V.: 0 warning letters, 3 recalls, 0 approval records, 0 Form 483s.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Side by side
D.O.R.C. Dutch Opthalmic Research Center Intl B.V. — Warning letters0
Philips North America — Warning letters0
D.O.R.C. Dutch Opthalmic Research Center Intl B.V. — Recalls3
Philips North America — Recalls355
D.O.R.C. Dutch Opthalmic Research Center Intl B.V. — Approval records0
Philips North America — Approval records0
D.O.R.C. Dutch Opthalmic Research Center Intl B.V. — Form 483s0
Philips North America — Form 483s0
Timeline
D.O.R.C. Dutch Opthalmic Research Center Intl B.V.
Most recent FDA action: June 17, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"D.O.R.C. Dutch Opthalmic Research Center Intl B.V. vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/d-o-r-c-dutch-opthalmic-research-center-intl-b-v-vs-philips-north-america
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗